Cart (0 Items)
Your cart is currently empty.
View ProductsStable Isotope Labelled Obinutuzumab Biosimilar – Anti-MS4A1/CD20 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Isotope Labelled Obinutuzumab Biosimilar - Anti-MS4A1/CD20 mAb - Research Grade |
|---|---|
| Source | CAS 949142-50-1 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Molecular weight | 150kDa |
| Purity | >95% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | MS |
| Aliases /Synonyms | GA101,RG7159,RO5072759,afutuzumab |
| Reference | PX-TA1172-SIL |
| Related Products | PX-P3060 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
Description of Stable Isotope Labelled Obinutuzumab Biosimilar - Anti-MS4A1/CD20 mAb - Research Grade
General information on Anti-MS4A1/CD20(Homo sapiens) (Obinutuzumab) Monoclonal Antibody
Obinutuzumab is a humanized monoclonal antibody that can be used in combination with chlorambucil to treat chronic lymphocytic leukemia. It was sold under the Gazyva brand. There are black box warnings of fatal hepatitis B virus (HBV) reactivation and fatal progressive multifocal leukoencephalopathy (PML).
Reviews
Il n’y a pas encore d’avis.